Shares Spotlight webinars feature presentations from directors of companies explaining their investment propositions followed by an opportunity for you to ask questions. This is your chance to hear first-hand from the directors of companies and how they are going to generate shareholder value.
Registering and joining us for webinar is very simple; simply register your details and follow the link you will receive in your confirmation email at the scheduled time of the webinar.
The following companies will be presenting:
Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of cannabidiol as an anti-fibrotic and anti-inflammatory therapy for the treatment of cardiovascular disease. The Companys lead product candidate, CardiolRx™, is a pharmaceutically produced oral cannabidiol formulation that is being clinically developed for use in cardiovascular medicine.
ThruVision (THRU) are global providers of fast, safe and respectful people security screening technology for transportation, border control and loss prevention.
Click on the REGISTER tab now to secure your place!
Who Should Attend
The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.
The webinar will not require your participation in the form of audio or video, however you will have the opportunity to ask questions of the presenters via an online chat window during the presentation.
Evening timings
18.00
Introduction
Chris Williams, Spotlight Manager - Shares
18.05
ThruVision
Colin Evans, CEO - Thruvision (THRU)
18.30
Cardiol Therapeutics
David Elsley, President and CEO - Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL)
18.55
End of webinar
Sponsored by
Featured Companies
